Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04
Michael Joyce(University of Alberta), Gary J. Nabel(National Institutes of Health), Yongping Yang(National Institutes of Health), Jeffrey C. Boyington(National Institutes of Health), Peter D. Kwong(National Institutes of Health), Anqi Zheng(Peking University), Masaru Kanekiyo, Stephanie Moquin(NovaBay Pharmaceuticals (United States)), John R. Mascola(National Institute of Allergy and Infectious Diseases), Wei Shi(National Institutes of Health), Xueling Wu(National Institutes of Health), Baoshan Zhang(National Institutes of Health), Jiang Zhu(Xiamen University), Ling Xu(University of Vienna), Tongqing Zhou(National Institutes of Health), Zhi-Yong Yang(University of Vienna), Christian Biertümpfel(National Institutes of Health)
Cited by 36
Related Papers
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k